Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Sales (2021 - 2025)

Lucid Diagnostics' Return on Sales history spans 5 years, with the latest figure at 10.84% for Q4 2025.

  • For Q4 2025, Return on Sales fell 120.0% year-over-year to 10.84%; the TTM value through Dec 2025 reached 12.27%, down 179.0%, while the annual FY2025 figure was 12.34%, 187.0% down from the prior year.
  • Return on Sales reached 10.84% in Q4 2025 per LUCD's latest filing, down from 8.66% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 41.93% in Q2 2021 to a low of 188.8% in Q3 2022.
  • Average Return on Sales over 5 years is 37.76%, with a median of 18.15% recorded in 2023.
  • Peak YoY movement for Return on Sales: plummeted -15402bps in 2022, then surged 17066bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 37.69% in 2021, then crashed by -254bps to 133.29% in 2022, then skyrocketed by 92bps to 10.41% in 2023, then grew by 7bps to 9.64% in 2024, then decreased by -12bps to 10.84% in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Return on Sales are 10.84% (Q4 2025), 8.66% (Q3 2025), and 3.7% (Q2 2025).